Jonathan M. Schwartz

1.2k total citations
44 papers, 758 citations indexed

About

Jonathan M. Schwartz is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Jonathan M. Schwartz has authored 44 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hepatology, 16 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Jonathan M. Schwartz's work include Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Jonathan M. Schwartz is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Jonathan M. Schwartz collaborates with scholars based in United States, Israel and Denmark. Jonathan M. Schwartz's co-authors include John F. Reinus, Marcus Shaker, Susan L. Orloff, J. M. Ham, Roberto DeFranchis, K. Yassin, Glenn M. Eisen, Douglas O. Faigel, Federica Villa and A. Zaman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Contemporary Sociology A Journal of Reviews.

In The Last Decade

Jonathan M. Schwartz

40 papers receiving 731 citations

Peers

Countries citing papers authored by Jonathan M. Schwartz

Since Specialization

Citations

This map shows the geographic impact of Jonathan M. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan M. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan M. Schwartz more than expected).

Fields of papers citing papers by Jonathan M. Schwartz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan M. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan M. Schwartz. The network helps show where Jonathan M. Schwartz may publish in the future.

Co-authorship network of co-authors of Jonathan M. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan M. Schwartz. A scholar is included among the top collaborators of Jonathan M. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan M. Schwartz. Jonathan M. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Impact of Metabolic Health and Obesity on Liver Transplant Candidates and Recipients 2024 ·Life ·Alexander S. Vogel, (unknown), Dagny Von Ahrens, Brett E. Fortune, Jonathan M. Schwartz, (unknown), Kristina R. Chacko, Clara Tow	0
2	Physical Activity Is Associated with Slower Cognitive Decline in Older Adults with Type 2 Diabetes 2023 ·The Journal of Prevention of Alzheimer s Disease ·(unknown), Ramit Ravona‐Springer, Anthony Heymann, Erin Moshier, (unknown), Jonathan M. Schwartz, Mary Sano, (unknown), Michal Schnaider Beeri	6
3	Quality of Life in Emicizumab-Treated People with Hemophilia A in the ATHN 7 Hemophilia Natural History Study - an Assessment of Baseline PROMIS®-29 Scores 2023 ·Blood ·Tyler W. Buckner, (unknown), Lucy Lee, Elise Lim, Jonathan M. Schwartz, Karina Raimundo, Michael Recht	1
4	Increase in Number of Depression Symptoms Over Time is Related to Worse Cognitive Outcomes in Older Adults With Type 2 Diabetes 2020 ·American Journal of Geriatric Psychiatry ·Ramit Ravona‐Springer, Anthony Heymann, Hung‐Mo Lin, Xiaoyu Liu, (unknown), Jonathan M. Schwartz, Laili Soleimani, Mary Sano, Michal Schnaider Beeri	12
5	Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients 2018 ·Canadian Journal of Gastroenterology and Hepatology ·Justin Tang, Nitin Ohri, Rafi Kabarriti, Santiago Aparo, (unknown), Sanjay Goel, Jonathan M. Schwartz, Milan Kinkhabwala, Andreas Kaubisch, Chandan Guha	3
6	Symptom Distress in Patients With End-Stage Liver Disease Toward the End of Life 2015 ·Gastroenterology Nursing ·Lissi Hansen, Michael C. Leo, Michael F. Chang, Atif Zaman, (unknown), Jonathan M. Schwartz	24
7	Survival analysis of Hispanics in a cohort of patients with hepatocellular carcinoma 2014 ·Cancer ·Santiago Aparo, Sanjay Goel, (unknown), Nitin Ohri, Jonathan M. Schwartz, Yungtai Lo, Andreas Kaubisch	10
8	Evaluation and management of abnormal liver chemistry tests in the asymptomatic outpatient 2009 ·(unknown), Jonathan M. Schwartz	2
9	Uveitis in Patients with Autoimmune Hepatitis 2009 ·American Journal of Ophthalmology ·Lyndell L. Lim, John D. Scarborough, Jennifer E. Thorne, E M Graham, John H. Kempen, Friederike Mackensen, Quan Dong Nguyen, (unknown), Russell W. Read, Eric B. Suhler, Jonathan M. Schwartz, Justine R. Smith	14
10	Interaction of Stress and Lead Burden on Cognition in Older Men: The VA Normative Aging Study 2008 ·Epidemiology ·Jean Peters, (unknown), (unknown), Avron Spiro, Jonathan M. Schwartz, David Sparrow, (unknown), He‐Ying Hu	3
11	Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis 2008 ·The American Journal of Surgery ·Swee H. Teh, Brett C. Sheppard, Jonathan M. Schwartz, Susan L. Orloff	40
12	The Accuracy of PillCam ESO Capsule Endoscopy Versus Conventional Upper Endoscopy for the Diagnosis of Esophageal Varices: A Prospective Three-Center Pilot Study 2006 ·Endoscopy ·Glenn M. Eisen, Rami Eliakim, A. Zaman, Jonathan M. Schwartz, Douglas O. Faigel, Emanuele Rondonotti, Federica Villa, (unknown), K. Yassin, Roberto DeFranchis	111
13	Liver Transplantation for Hepatocellular Carcinoma 2006 ·Journal of Clinical Gastroenterology ·(unknown), Jonathan M. Schwartz, Stephen C. Rayhill, Hugo R. Rosen, Scott J. Cotler	17
14	Hepatitis C infection increases the risk of new-onset diabetes after transplantation in liver allograft recipients 2005 ·The American Journal of Surgery ·(unknown), Ali J. Olyaei, (unknown), (unknown), Jonathan M. Schwartz, (unknown), J. M. Ham, Susan L. Orloff	28
15	Cardiopulmonary Consequences of Transjugular Intrahepatic Portosystemic Shunts 2004 ·Journal of Clinical Gastroenterology ·Jonathan M. Schwartz, (unknown), Sandra J. Althaus, Anne M. Larson, Atif Zaman, David J. Glickerman, Kris V. Kowdley	24
16	Treatment of Hepatitis C in Solid Organ Transplantation 2004 ·Drugs ·(unknown), Jonathan M. Schwartz, Hugo R. Rosen	6
17	Treatment of hepatocellular carcinoma 2003 ·Current Treatment Options in Gastroenterology ·Jonathan M. Schwartz, J. M. Ham	22
18	Severe Gastrointestinal Bleeding After Hematopoietic Cell Transplantation, 1987–1997: Incidence, Causes, and Outcome 2001 ·The American Journal of Gastroenterology ·Jonathan M. Schwartz, (unknown), Mark Thornquist, David M. Hockenbery, Carol S. Murakami, Fred Drennan, (unknown), Simone I. Strasser, (unknown), Harpreet S. Brar, Cynthia W. Ko, Michael D. Saunders, (unknown), George B. McDonald	22
19	Ischemic Hepatitis in a Patient with Congestive Cardiomyopathy: An Innovative Approach to Therapy Using Intravenous Dobutamine 1994 ·The Journal of Clinical Pharmacology ·(unknown), Jonathan M. Schwartz, William H. Frishman, Michael Schwarz, Thierry H. LeJemtel	2
20	Wound healing in normal and analbuminemic (NAR) rats 1987 ·Journal of Surgical Research ·(unknown), Jonathan M. Schwartz, (unknown), Stanley Μ. Levenson, Achilles A. Demetriou	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact